BCRX
BioCryst Pharmaceuticals Inc
Price:  
9.84 
USD
Volume:  
4,859,295.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BCRX Stock Forecast & Price Target

BCRX Stock Price Forecast

The average stock forecast for BioCryst Pharmaceuticals Inc (BCRX) in the next 12 months is 21.73 USD. This price target corresponds to an upside of 120.79%. The range of stock forecasts for BCRX is 13.13 - 33.60 USD. Based on the ratings of 16 analysts, the consensus recommendation for BCRX is BUY.
Target Low Average Median High
Price (USD) 13.13 21.73 19.38 33.60
Upside 33.43% 120.79% 96.95% 241.46%

Recommendation Trends

The latest consensus rating for BCRX is "BUY". This is the average recommendation of 16 analysts: 0 strong sell, 0 sell, 1 hold, 10 buy, 5 strong buy. In the previous period, 16 analysts also majorly recommmended "BUY" for BCRX.

BCRX Financial Stock Forecast

Revenue This Year
680.79M
-22.18%
from 874.84M
Revenue Next Year
740.48M
8.77%
from 680.79M
EPS This Year
-2.17
-279.88%
from 1.21
EPS Next Year
0.34
-115.51%
from -2.17